MedStar Authors catalog › Details for: Techniques to optimize the use of optical coherence tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database.
Normal view MARC view ISBD view

Techniques to optimize the use of optical coherence tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database.

by Shlofmitz, Evan; Garcia-Garcia, Hector M; Rogers, Toby; Khalid, Nauman; Chen, Yuefeng; Kajita, Alexandre H; Khan, Jaffar M; Iantorno, Micaela; Gallino, Robert; Bernardo, Nelson L; Hashim, Hayder; Torguson, Rebecca; Waksman, Ron.
Citation: Cardiovascular Revascularization Medicine. 2019 Mar 15.Journal: Cardiovascular revascularization medicine : including molecular interventions.Published: ; 2019ISSN: 1878-0938.Full author list: Shlofmitz E; Garcia-Garcia HM; Rogers T; Khalid N; Chen Y; Kajita AH; Khan JM; Iantorno M; Gallino RA; Bernardo NL; Hashim H; Torguson R; Waksman R.UI/PMID: 30962083.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.carrev.2019.03.009 (Click here) Abbreviated citation: Cardiovasc Revasc Med. 2019 Mar 15.Local Holdings: Available in print through MWHC library: 2002 - present.Abstract: BACKGROUND/PURPOSE: Optical coherence tomography (OCT) is a high-resolution intravascular imaging modality used to assess coronary arteries and as an adjunctive tool for optimization of percutaneous coronary interventions. Overall, the rate of complications and adverse events related to intravascular imaging is low. Limited data exist on the most commonly reported complications and modes of failure related to the use of OCT. Therefore, we analyzed the post-marketing surveillance data from the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database to assess the reported complications and failure modes for OCT and reviewed techniques to optimize device use.Abstract: METHODS/MATERIALS: The MAUDE database was queried for all event reports involving coronary OCT devices. Two independent reviewers identified 49 device reports included in the final analysis. Modes of failure and device-related patient complications were assessed.Abstract: RESULTS: Of the 49 cases with reported device-related issues, 6.1% involved malfunction prior to insertion of the OCT catheter, and 30.6% of reported events did not result in an associated patient-related adverse event. The most commonly reported adverse events included coronary dissection and difficulty removing the catheter within a previously stented segment. No events of contrast-induced nephropathy were reported.Abstract: CONCLUSIONS: Findings from the MAUDE database highlight the modes of device-related events associated with OCT. Device issues are uncommon, and as a result, users should be aware of optimal techniques to prevent and minimize adverse events related to device use.Abstract: Copyright (c) 2019 Elsevier Inc. All rights reserved.

Powered by Koha